Navigating the Complexities of Ph Negative ALL - Part I

Speciality: Oncology


Speaker:

Dr. Dinesh Bhurani | Director, Department of Hemato-oncology, RGCIRC

Dr. Narendra Agarwal | Sr. Consultant, Hematology, RGCIRC

Dr. Rayaz Ahmed | Sr. Consultant, Hematology, RGICIRC

Dr. Narender Tejwani | Consultant Hematopathology, RGCIRC

Dr. Sharat Damodar | Chief of Hematology and Transplant Services Mazumdar Shaw Medical Centre, Narayan Health City, Bangalore

Description:

A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.

Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.

Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.

Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
 
Therefore,  have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 



See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

2.

Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.

3.

Long-term study links chronic conditions in midlife to higher cancer risk and mortality

4.

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

5.

When does a melanoma metastasize? Implications for management


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot